Tamoxifen — sold as Nolvadex — is a selective oestrogen receptor modulator (SERM). It does not lower oestrogen. It blocks oestrogen from acting at specific receptors while leaving it active at others. That distinction is the whole reason it works for post-cycle recovery and is a poor choice for on-cycle oestrogen control.
Blocking is not lowering
This is the point most explanations skip. An aromatase inhibitor stops testosterone converting to oestrogen, so blood oestradiol falls. Tamoxifen leaves oestradiol exactly where it was and occupies the receptor instead.
“Selective” means it does this differently in different tissues:
- Breast tissue — blocks. This is why it addresses gynecomastia.
- Hypothalamus and pituitary — blocks. The brain reads low oestrogen signalling, so it raises LH and FSH, which restarts testicular testosterone production. This is the mechanism that makes it a PCT drug.
- Bone and liver — acts like oestrogen. Which is why it does not wreck bone density or lipids the way an aromatase inhibitor can.
Why it works for PCT
After a cycle, your own testosterone production is suppressed because exogenous hormone told the brain to stop signalling. Recovery requires that signal to restart.
Tamoxifen blocks oestrogen feedback at the hypothalamus, the brain concludes hormone levels are low, and LH and FSH rise. The testes get the message to resume. That is the entire basis of a post-cycle therapy protocol.
It is typically run for four to six weeks, started once the last compound has cleared — which depends on the ester. Starting while a long-ester compound is still circulating wastes the protocol, because the suppression signal is still present. We cover the timing in propionate vs enanthate.
On gynecomastia
Tamoxifen is the standard response to early gynecomastia because it blocks the receptor in breast tissue directly. Two things worth being clear about:
- It works on early, tender, developing tissue. Caught early, it can halt and often reverse the process.
- It does not remove established glandular tissue. Once the gland has formed and settled, no drug removes it — that becomes a surgical question. This is why acting on early tenderness matters so much.
Why it is a poor on-cycle choice
Because it does not lower oestradiol, tamoxifen does nothing about the effects driven by circulating oestrogen levels rather than receptor activity — water retention and blood pressure in particular. Someone using it on cycle to control bloating is using the wrong tool.
It also interacts awkwardly with aromatase inhibitors, altering their blood levels. If you are using both, that is a reason for blood work rather than guesswork.
Side effects worth knowing
Generally well tolerated at the doses used here, but not inert:
- Visual disturbance — uncommon but real, and a reason to stop and seek medical advice rather than push through
- Mood changes and low libido — commonly reported, particularly at higher doses
- Raised clot risk — the clinically significant one. Relevant if you have any personal or family history of thrombosis
- Nausea and hot flushes
Legal and practical position
Tamoxifen is a prescription-only medicine in the UK — not a controlled drug, so the offence structure differs from anabolic steroids. It is a well-established medicine with decades of clinical use, which is precisely why self-directed use without blood work is an odd choice: the monitoring that makes it safe is the part people skip.
Our tamoxifen category carries 76 lines. It appears under both names — Tamoxifen and Nolvadex — plus brand variants like Altamofen and Nolvamed, which fragments the category the same way stanozolol does.
Frequently asked questions
Is Nolvadex the same as tamoxifen?
Yes. Nolvadex is the original trade name; tamoxifen is the compound. Altamofen, Nolvamed and similar are brand variants of the same thing.
Should I take tamoxifen on cycle or after?
Its main role is after, for recovery. On cycle it addresses gynecomastia at the receptor but does nothing about water retention or blood pressure, because it does not lower oestradiol.
Can tamoxifen reverse gyno?
Early, tender, developing tissue — often yes. Established glandular tissue — no, that is surgical. Acting on the first sign is what determines which situation you are in.